Review
Advances in epidemiology, etiology, and treatment of community-acquired pneumonia
Jiang Ning, Long Qiuyue, Zheng Yali, Gao Zhancheng
Published 2023-01-06
Cite as Chin J Prev Med, 2023, 57(1): 91-99. DOI: 10.3760/cma.j.cn112150-20220308-00214
Abstract
Community-acquired pneumonia (CAP) is the third leading cause of death worldwide and one of the most commonly infectious diseases. Its epidemiological characteristics vary with host and immune status, and corresponding pathogen spectrums migrate over time and space distribution. Meanwhile, with the outbreak of COVID-19, some unconventional treatment strategies are on the rise. This article reviewed the epidemiological characteristics, pathogen spectrum and treatment direction of CAP in China over the years, and aimed to provide guidance for the diagnosis and treatment of CAP in clinical practice.
Key words:
Pneumonia; Community-acqiured infections; Epidemiology; Therapeutics; Etiology
Contributor Information
Jiang Ning
Department of Respiratory and Critical Care Medicine, Peking University People′s Hospital, Beijing 100044, China
Long Qiuyue
Department of Respiratory, Critical Care and Sleep Medicine, Xiang′an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, China
Zheng Yali
Department of Respiratory, Critical Care and Sleep Medicine, Xiang′an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, China
Gao Zhancheng
Department of Respiratory and Critical Care Medicine, Peking University People′s Hospital, Beijing 100044, China